bleomycetin has been researched along with Invasiveness, Neoplasm in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, J; Pan, J; Qi, W; Su, B; Wu, S; Zhang, J; Zhang, L | 1 |
Li, Q; Pan, E; Peng, LX; Yang, BB; Zhao, HS; Zhao, P | 1 |
Gong, L; Liu, H; Lou, JY; Peng, ZL; Wang, P; Zhang, JW | 1 |
3 other study(ies) available for bleomycetin and Invasiveness, Neoplasm
Article | Year |
---|---|
Synergistic effect of nanosecond pulsed electric field combined with low-dose of pingyangmycin on salivary adenoid cystic carcinoma.
Topics: Apoptosis; Basigin; Bleomycin; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Neoplasm Invasiveness; Pulsed Radiofrequency Treatment; Salivary Gland Neoplasms; Salivary Glands | 2014 |
Phosphoinositide 3-kinase/Akt pathway is involved in pingyangmycin‑induced growth inhibition, apoptosis and reduction of invasive potential in EOMA mouse hemangioendothelioma cells.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Bleomycin; Cell Line; Cell Proliferation; Hemangioendothelioma; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2015 |
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Hysterectomy; Ifosfamide; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |